AlphaFold predicted structure
SGSM3 · Q96HU1

Mean pLDDT
82.6/ 100
Confident
749 residues
Confidence breakdown
- Very high(≥ 90)50%
- Confident(70–90)29%
- Low(50–70)11%
- Very low(< 50)10%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
small G protein signaling modulator 3
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Intellectual disability
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalnervous system benign neoplasm
smoking initiation
Uterine leiomyoma
hypertrophic cardiomyopathy
thyroid gland disorder
Intellectual disability
neurodevelopmental disorder
autism
breast carcinoma
Abnormality of the liver
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Small G protein signaling modulator 3
GTPase-activating protein (GAP) specific for Rab5 small GTPase for which it accelerates the intrinsic GTP hydrolysis rate, thereby controlling trafficking through the early endocytic pathway (PubMed:16086013, PubMed:17562788). May play a cooperative role in NF2-mediated growth suppression of cells
SGSM3 · Q96HU1

Mean pLDDT
82.6/ 100
Confident
749 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0